FAQ

Nicotine Transdermal Patch

Known as: Transdermal Patch, Nicotine, Patch, Nicotine Transdermal, nicotine patches 
A transdermal patch containing the alkaloid nicotine with nicotine replacement activity. Upon administration of the patch, nicotine is slowly… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1947-2018
020406019472017

Related topics

Related topics

2 relations

Broader (2)

Nicotinenicotine replacement

Related mentions per year

Related mentions per year

1938-2018
19401960198020002020
Nicotine Transdermal Patch
Nicotine
nicotine replacement

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Electronic cigarettes for smoking cessation: a randomised controlled trial.
BACKGROUND Electronic cigarettes (e-cigarettes) can deliver nicotine and mitigate tobacco withdrawal and are used by many smokers… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial
BACKGROUND Varenicline, a new treatment for smoking cessation, has demonstrated significantly greater efficacy over placebo and… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease
Rationale: Acute nicotine injections have been found to improve attentional performance in patients with Alzheimer’s disease (AD… (More)
  • table 1
  • figure 2
  • figure 1
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… (More)
Is this relevant?
1998
1998
Smoking cessation among inner-city African Americans unsing the nicotine transdermal patch
OBJECTIVE: To determine the efficacy of the transdermal nicotine patch for smoking cessation in inner-city African Americans… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
1997
1997
The cost-effectiveness of the nicotine transdermal patch for smoking cessation.
BACKGROUND Smoking is the single most preventable cause of premature mortality in the United States. In 13 double-blind… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Modulation of oxidant stress in vivo in chronic cigarette smokers.
BACKGROUND Free radical-induced oxidative damage is thought to be involved in the pathogenesis of diseases associated with… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling.
OBJECTIVE To determine the incremental cost-effectiveness of the transdermal nicotine patch. DESIGN Decision analytic model… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Transdermal nicotine for active ulcerative colitis.
BACKGROUND Ulcerative colitis is largely a disease of nonsmokers. Because anecdotal reports suggest that smoking and nicotine may… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Predicting smoking cessation. Who will quit with and without the nicotine patch.
OBJECTIVE To identify predictors of smoking cessation success or failure with and without transdermal nicotine patch treatment… (More)
Is this relevant?